Status:
COMPLETED
Results of Peripheral Blood Stem Cells According to Stimulatory Molecule,: Zarzio Versus Granocytes
Lead Sponsor:
University Hospital, Brest
Conditions:
Hematology, Graft, Mobilization
Eligibility:
All Genders
18-70 years
Brief Summary
Investigator therefore propose a retrospective mono-centric study, to compare the results obtained in patients with myeloma or lymphoma, mobilized with Zarzio® in order to obtain a graft, with the res...
Detailed Description
Autologous cell therapy remains the standard treatment in lymphomas (Hodgkin or non Hodgkin) and myelomas in the first line if they have bad prognostic factors or second-line cases of relapsed or rela...
Eligibility Criteria
Inclusion
- \- Age supérieur to 8 year
- Recommandation of ABSCT
Exclusion
- \- No indication of ABSCT
- Age inférieur to 18 years
Key Trial Info
Start Date :
October 10 2016
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 23 2017
Estimated Enrollment :
70 Patients enrolled
Trial Details
Trial ID
NCT03367117
Start Date
October 10 2016
End Date
January 23 2017
Last Update
December 8 2017
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.